Due to differences in hair growth rare depending on anatomical region, age,
gender, ethnicity and interindividual variability, interpretation of paren
t drug or/and metabolite concentrations in hair is not easy. Furthermore, a
s drug incorporation mechanisms into hair matrix is not yet fully understoo
d, it is rather difficult to extrapolate details on time and dose from hair
segment analysis. If incorporation sources other than from bloodstream (sk
in secretions and/or external/environmental contamination) are considered,
interpretation becomes even more complicated. For evaluating possible passi
ve contamination, it is essential to consider specific identification of me
tabolites, use of metabolite-to-parent drug ratios, assays of decontaminati
on washes and analysis of specimens collected from other body parts. Cosmet
ic hair treatment, natural and artificial hair colour, differences in hair
structure and specificity of analytical methodology may represent other bia
s sources affecting concentrations of drugs in hair. A suitable cut-off lev
el related to the LOD will allow correct identification of drugs or metabol
ites in hair. Regarding the performance of different hair testing laborator
ies, little information is available at this time to what extent test resul
ts are comparable and their interpretation is consistent. Frequency of drug
consumption and time intervals between multiple consumption or lag time be
tween consumption and appearance in the hair has not been fully investigate
d and needs further research. (C) 2000 Elsevier Science Ireland Ltd. All ri
ghts reserved.